Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma
MedComm · 2025-07 · 6 (7)
DOI: 10.1002/mco2.70190 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 16.06.2025. Verfasst von Lan Mi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Lymphoma Peking University Cancer Hospital & Instit…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Molecular subtyping in diffuse large B‐cell lymphoma (DLBCL) leads to facilitating drug selection. However, an integrated prognostic model based on molecular subtyping and clinical features has not been well established. Here, we retrospectively performed whole genome sequencing, whole exome sequencing, and fluorescence in situ hybridization in newly diagnosed DLBCLs, established a simplified LymphType algorithm for classification evaluation, and proposed a new integrated prognostic stratification system, combined molecular subtypes and International Prognostic Index (IPI) scoring system in our in‐house sequencing cohort ( N = 100), and validated in three public cohorts ( N = 1480). Compared with IPI scoring system and classification algorithm model alone, the discrimination ability of prognostic model based on the new integrated model showed best discrimination of overall survival with concordance index value (0.773 vs. 0.724 vs. 0.648). We subsequently established a four‐category risk model defined for the integrated prognostic model as follows: low, low‐intermediate, high‐intermediate, and high risk, demonstrating stronger prognostic separation across all end points (all p < 0.001) in our in‐house cohort and three validation cohorts. Collectively, the new feasible integrated prognostic stratification system contributes to accurate prognosis assessment in clinical routine and provides a new basis for the follow‐up treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Lymphoma Peking University Cancer Hospital & Institute Beijing China.
- Department of Medical Oncology Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China Chengdu China.
- Department of Medical Affairs Acornmed Biotechnology Co., Ltd. Beijing China.
- Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing China.
- Center for Precision Medicine Multi-Omics Research Institute of Advanced Clinical Medicine Peking University Beijing China.
- Department of Biomedical Informatics School of Basic Medical Sciences Peking University Health Science Center Beijing China.
ORCID-Profile: Jiayue Qin
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- Beijing Xisike Clinical Oncology Research Foundation
Zitieren
APA
Mi, L., Deng, J., Qin, J., Zhang, C., Liu, L., Yang, S., Chen, L., Wu, H. J., Wang, H., Zhu, J., Chen, H., Lou, F., Cao, S., Song, Y., & Liu, W. (2025). Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma. MedComm, 6(7). https://doi.org/10.1002/mco2.70190
Vancouver
Mi L, Deng J, Qin J, Zhang C, Liu L, Yang S, et al. Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma. MedComm. 2025;6(7). doi:10.1002/mco2.70190
BibTeX
@article{Mi2025,
author = {Mi, Lan and Deng, Jili and Qin, Jiayue and Zhang, Chen and Liu, Lixia and Yang, Shunli and Chen, Libin and Wu, Hua-Jun and Wang, Haojie and Zhu, Jun and Chen, Hong and Lou, Feng and Cao, Shanbo and Song, Yuqin and Liu, Weiping},
title = {Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma},
journal = {MedComm},
year = {2025},
volume = {6},
number = {7},
doi = {10.1002/mco2.70190}
}
EUVIMED